It has been reported that approximately 10% to 16% of T cell acute lymphoblastic leukemia (T-ALL) cases carry mutations altering the DNA-binding properties of BCL11B [18]. The gene discussed is BCL11B; the disease is acute lymphoblastic leukemia.